<DOC>
	<DOCNO>NCT00789854</DOCNO>
	<brief_summary>The primary objective study evaluate efficacy Quetiapine extend release ( XR ) combination selective serotonin reuptake inhibitor ( SSRI ) Venlafaxine versus Lithium combination selective serotonin reuptake inhibitor Venlafaxine versus Quetiapine extend release monotherapy subject treatment resistant depression assess change randomisation week 6 Montgomery-Åsberg Depression Rating Scale ( MADRS ) total score . As independent objective , primary objective also evaluate two subgroup patient : ( 1 ) patient resistant two previous antidepressant therapy ( 2 ) subgroup patient one previous failure .</brief_summary>
	<brief_title>Comparing Quetiapine XR Monotherapy Augmentation With Lithium Augmentation TRD Patients</brief_title>
	<detailed_description>The secondary objective study compare effect three different treatment regimen assess follow variable , applicable , change randomisation week 6 ( end study ) . Additionally time onset therapeutic effect assess evaluate efficacy data first four day ( Day 4 ) treatment well first week treatment ( Day 8 ) . These analysis also perform subgroups patient 2 fail previous antidepressant patient 1 failure .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Depressive Disorder , Treatment-Resistant</mesh_term>
	<mesh_term>Venlafaxine Hydrochloride</mesh_term>
	<mesh_term>Lithium Carbonate</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<mesh_term>Serotonin Uptake Inhibitors</mesh_term>
	<criteria>Documented clinical diagnosis confirm M.I.N.I . meeting criterion Diagnostic Statistical Manual Mental disorder , 4th Edition ( DSMIV ) following:296.2x MDD , Single Episode296.3x MDD , Recurrent Episode Current episode depression present , least 42 day prior enrolment 18 month MADRSScore ≥ 25 enrolment randomisation Patients DSMIV Axis I disorder MDD within 6 month randomisation Patients diagnosis DSMIV Axis II disorder major impact patient 's current psychiatric status Patients , investigator 's judgment pose current serious suicidal homicidal risk , make suicide attempt within past 6 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Depression</keyword>
	<keyword>MDD</keyword>
	<keyword>TRD</keyword>
</DOC>